HOME >> BIOLOGY >> NEWS
Biosite reports on presentation of preliminary data from sepsis program

SAN DIEGO and BRUSSELS, Belgium Biosite Incorporated (Nasdaq:BSTE) today announced preliminary results of a sample collection study aimed at identifying a biomarker panel that could potentially aid in the assessment for risk of sepsis progression. Sepsis is an often fatal condition with limited therapeutic options. Clinical investigator, Emanuel P. Rivers, M.D., MPH, vice chairman and director of research at the department of emergency medicine at Henry Ford Hospital in Detroit, presented the data at the 27th International Symposium on Intensive Care and Emergency Medicine (ISICEM) in Brussels.

In this study, we identified a combination of three biomarkers that performed better when compared to several other individual biomarkers, said Dr. Rivers. This preliminary study suggests that these biomarkers may be a clinically useful tool in the assessment of risk of sepsis progression within 72 hours of patients presenting to the emergency department and meeting the diagnostic criteria for sepsis. We look forward to future studies that will be aimed at substantiating these findings.

We are encouraged by this study and will advance this sepsis biomarker panel to the next step in our clinical process, said Ken Buechler, Ph.D., Biosite president and chief scientific officer. We are on track to launch a prospective multi-center clinical study in the second quarter of 2007 to validate the clinical utility of this panel and compile data needed for an FDA submission.

The biomarkers on the panel, neutrophil gelatinase-associated lipocalin (NGAL), c-reactive protein (CRP), and macrophage inflammatory protein-3 (MIP-3), were selected from 150 biomarkers studied through the Biosite Discovery program. The panel incorporates Biosites proprietary MultiMarker Index (MMX) Value feature that uses an algorithm to generate a single quantitative result from multiple simultaneous biomarker measurements. Biosite intends to commercialize the panel of biomarkers
'"/>

Contact: Nicole Beckstrand
nbeckstrand@biosite.com
858-805-2803
Biosite Incorporated
28-Mar-2007


Page: 1 2

Related biology news :

1. ChemGenex reports successful personalized dosing of Quinamed at ASCO
2. 1 month post launch, Interactive Autism Network reports 13,000 participants
3. Biolex reports potential for more potent, efficacious antibodies in Nature Biotechnology
4. Orexigen reports positive phase II results for Excalia Combination-Therapy to treat obesity
5. Dinosaurs climate shifted too, reports show
6. The New England Journal of Medicine reports data on eculizumab for the treatment of PNH
7. Portion distortion may contribute to expanding waistlines, study reports
8. Study reports findings on lung cancer death rates in never smokers
9. Breast implants not associated with cancer risk, study reports
10. Paper reports discovery of virus implicated in genetics of prostate cancer
11. First analysis of FDAs mifepristone adverse event reports

Post Your Comments:
(Date:4/16/2014)... store memories improves during childhood, associated with structural ... prefrontal and parietal cortices. New research from UC ... at this crucial time. Eventually, that could give ... transition into and during adolescence and affect memory, ... in the middle of the brain, the hippocampus ...
(Date:4/16/2014)... Dr. Klaus Aktories and Dr. Panagiotis Papatheodorou from the ... the University of Freiburg have discovered the receptor responsible ... perfringens into the cell. The TpeL toxin, which ... that causes gas gangrene and food poisoning. It is ... germs of the genus Clostridium . The toxins ...
(Date:4/15/2014)... 15, 2014, Irvine, Calif. UC Irvine neurobiologists have ... results when transplanted into the brains of mice with ... trial is published in the journal Stem Cells ... shown to work in two different mouse models. ... of dementia, is associated with accumulation of the protein ...
Breaking Biology News(10 mins):How kids' brain structures grow as memory develops 2Gate for bacterial toxins found 2UCI study finds modified stem cells offer potential pathway to treat Alzheimer's disease 2
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
Cached News: